Reactivation of Epstein–Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment

Epstein–Barr virus infection is most commonly asymptomatic in the acute setting, where the end result of infection is the adoption of a viral latency phenotype. The virus can reactivate later in life leading to the abnormal proliferation of the infected B, T, or NK cells. Hereby, we report a 71-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Febres-Aldana, Anthony J., Febres-Aldana, Christopher A., Dvir, Kathrin, Galarza-Fortuna, Gliceida, Schwartz, Michael, Medina, Ana M., Sriganeshan, Vathany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171624/
https://www.ncbi.nlm.nih.gov/pubmed/32328321
http://dx.doi.org/10.1155/2020/3641813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171624/
https://www.ncbi.nlm.nih.gov/pubmed/32328321
http://dx.doi.org/10.1155/2020/3641813

Ejemplares similares